Current uses of chlorhexidine for management of oral disease: a narrative review

ZLS Brookes, R Bescos, LA Belfield, K Ali, A Roberts - Journal of dentistry, 2020 - Elsevier
Objectives Chlorhexidine (CHX) is a commonly used antiseptic mouthwash, used by dental
practitioners and the public, due to its antimicrobial effects. The aim of this article was to …

[HTML][HTML] Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw

L He, X Sun, Z Liu, Y Qiu, Y Niu - International journal of oral science, 2020 - nature.com
Medication-related osteonecrosis of the jaw (MRONJ) is a serious side effect of bone-
modifying agents and inhibits angiogenesis agents. Although the pathogenesis of MRONJ is …

[HTML][HTML] Medication-related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020

G Campisi, R Mauceri, F Bertoldo, G Bettini, M Biasotto… - 2020 - mdpi.com
The Medication-Related Osteonecrosis of Jaws (MRONJ) diagnosis process and its
prevention play a role of great and rising importance, not only on the Quality of Life (QoL) of …

[HTML][HTML] Medication-related osteonecrosis of the jaw: a review

NA AlDhalaan, A BaQais, A Al-Omar - Cureus, 2020 - ncbi.nlm.nih.gov
Medication-related osteonecrosis of the jaw (MRONJ) is a rare, severe debilitating condition
from unknown causes. It is characterized by nonhealing exposed bone in a patient with a …

[HTML][HTML] Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors

JT Wan, DM Sheeley, MJ Somerman, JS Lee - Bone research, 2020 - nature.com
It is well established that alterations in phosphate metabolism have a profound effect on
hard and soft tissues of the oral cavity. The present-day clinical form of osteonecrosis of the …

Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review

L Fortunato, F Bennardo, C Buffone… - Journal of Cranio …, 2020 - Elsevier
The aim of this systematic review was to answer the question: Is the application of
autologous platelet concentrates (APCs) effective in the prevention and treatment of …

[HTML][HTML] Management of medication-related osteonecrosis of the jaw (MRONJ) using leukocyte-and platelet-rich fibrin (L-PRF) and photobiomodulation: a …

G Tenore, A Zimbalatti, F Rocchetti, F Graniero… - Journal of Clinical …, 2020 - mdpi.com
Background. The aim of this study was to compare retrospectively the effect of three different
treatment protocols on the healing outcome in patients with established medication-related …

[HTML][HTML] Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug …

C Ottesen, M Schiodt, SS Jensen, T Kofod… - Oral Surgery, Oral …, 2022 - Elsevier
Objective. Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse
reaction to high-dose antiresorptive medication (AR) in patients with cancer. A temporary …

[HTML][HTML] The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists

R Mauceri, R Coniglio, A Abbinante, P Carcieri… - Supportive Care in …, 2022 - Springer
Purpose The prevention and early diagnosis of medication-related osteonecrosis of the jaw
(MRONJ) is fundamental to reducing the incidence and progression of MRONJ. Many in the …

Wound closure and alveoplasty after preventive tooth extractions in patients with antiresorptive intake—A randomized pilot trial

O Ristow, T Rückschloß, J Moratin, M Müller… - Oral …, 2021 - Wiley Online Library
Objectives To compare success rates between the sub‐periosteal prepared (SPP) muco‐
periosteal flap and the epi‐periosteal prepared (EPP) mucosa flap and the feasibility of …